| Literature DB >> 28670717 |
M Furue1,2, K Yamamura1, M Kido-Nakahara1, T Nakahara1, Y Fukui3,4.
Abstract
Atopic dermatitis (AD) is a chronic or chronically relapsing, eczematous, severely pruritic skin disorder associated with skin barrier dysfunction. The lesional skin of AD exhibits T helper 2 (TH 2)-deviated immune reactions. Interleukin-31 (IL-31), preferentially produced from TH 2 cells, is a potent pruritogenic cytokine, and its systemic and local administration induces scratching behavior in rodents, dogs and monkeys. Recent clinical trials have revealed that administration of an anti-IL-31 receptor antibody significantly alleviates pruritus in patients with AD. In this review, we summarize recent topics related to IL-31 and its receptor with special references to atopic itch.Entities:
Keywords: T helper 2; atopic dermatitis; interleukin-31; interleukin-31 receptor; pruritus
Mesh:
Substances:
Year: 2017 PMID: 28670717 DOI: 10.1111/all.13239
Source DB: PubMed Journal: Allergy ISSN: 0105-4538 Impact factor: 13.146